QDPR deficiency drives immune suppression in pancreatic cancer

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 8K citations · Full text

Life Sciences, Immunology, Oncology +17

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen, Diana Miao, Bastian Schilling et al. · Science · 2015 · 3K citations · Full text

Medicine, Cancer Biology, Oncology +17

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim, Răzvan Cristescu, Adam J. Bass et al. · Nature Medicine · 2018 · 1.7K citations

Medicine, Cancer Biology, Oncology +17

Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma

Junya Peng, Baofa Sun, Chuanyuan Chen et al. · Cell Research · 2019 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal, Catherine Lévy, Keli Turner et al. · Journal of Immunotherapy · 2010 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14